ZCZeliha Firat Cuylan

Zeliha Firat Cuylan

*This is an algorithmically generated author record based on publicly available information.

Zeliha Firat Cuylan has a total of 67 co-authors. Here are the top co-authors by number of shared publications:

  • Murat Oz

    Department of Gynecologic Oncology, Zekai Tahir Burak Women’s Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey

    6 shared publications
  • Ali Ayhan

    School of Medicine, Department of Obstetrics and Gynecology, Başkent University, Bahçelievler, Ankara, Turkey

    4 shared publications
  • Mehmet Mutlu Meydanli

    Department of Gynecologic Oncology, Zekai Tahir Burak Women’s Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey

    4 shared publications
  • Ali Ayhan

    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine Baskent University Ankara Turkey

    3 shared publications
  • Esra Kuscu

    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine Baskent University Ankara Turkey

    3 shared publications
  • Gonca Coban

    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Başkent University, Ankara, Turkey

    3 shared publications

Latest Publications

  • Open Access

    Differentiation of cervical cancer subtypes using machine learning models on MRI images

    by Asiye Sozeri, Neslihan Gokmen, Eda Kayali, Zeliha Firat Cuylan, Fatih Eroglu, Izzet Selcuk Parlak, Gunsu Kimyon Comert

    Purpose: To develop and compare various radiomics-based machine learning (ML) models for distinguishing cervical squamous cell carcinoma (SCC) from non-SCC histopathological subtypes, using multiparametric magnetic resonance imaging (MRI) and clinical data. Material and methods: This retrospective study included 88 women (mean age, 51.1 ±13.0 years; range, 25-83 years) with histopathologically confirmed cervical cancer (47 SCC, 41 non-SCC). For each patient, axial and sagittal T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) were available, along with clinical metadata. Radiomic features (shape, first-order, and texture features including gray-level co-occurrence matrix, gray-level run length matrix, and gray-level size zone matrix) were extracted from each sequence, yielding 945 features per patient. A feature set was created by combining features from all three sequences. The least absolute shrinkage and selection operator (LASSO) method was used for feature selection. Three supervised classifiers – random forest (RF), support vector machine (SVM), and logistic regression (LR) – were trained to classify SCC versus non-SCC. Results: Among the single-sequence models, the sagittal T2WI sequence demonstrated the strongest performance, achieving receiver operating characteristic (ROC) area under the curve (AUC) values of 0.839 with SVM and 0.732 with LR. In contrast, the axial T2WI RF model showed poor discriminative ability (ROC-AUC: 0.464), indicating that this sequence alone provides limited value for subtype differentiation despite showing acceptable accuracy metrics. The combined multi-sequence model yielded the highest overall performance. Using LASSO-selected features, RF achieved the best ROC-AUC (0.958), followed closely by SVM (0.953) and LR (0.951), with all models attaining accuracies above 0.91. Conclusions: Feature-level integration of axial T2WI, sagittal T2WI, and DWI substantially enhances ML performance in differentiating SCC from non-SCC cervical cancer subtypes. Compared with single-sequence models, the combined multi-sequence approach provides more robust and well-balanced classification, underscoring the complementary value of multiparametric MRI for histopathological subtype prediction.

  • Open Access

    Comparison of Grade 3 endometrioid type endometrial cancer with clear cell and serous type endometrial cancer in terms of clinicopathology and survival, and examination of prognostic factors affecting survival.

    by Fatma Nazlı Demir, Özgün Ceylan, Zeliha Fırat Cüylan, Bülent Özdal

    Aim: comparison of the similarities of grade 3 endometrioid type endometrial cancer with clear cell and serous type endometrial cancer in terms of clinicopathology and survival and examination of prognostic factors affecting survival. Material and methods: the medical records of 207 patients who were diagnosed with clear cell, serous and grade 3 endometrioid type endometrial cancer and who underwent surgery at Zekai Tahir Burak Women's Health Training and Research Hospital between June 2007 and September 2019 and at Ankara City Hospital between September 2019 and April 2022 were reviewed and their demographic, surgical and pathological features were analyzed. The patients were divided into two groups as grade 3 endometrioid type endometrial cancer and serous/clear cell endometrial cancer, and the patients were compared in terms of clinical and demographic features with univariate-multivariate analyses. Results: the mean age of the patients was 63.3±9.3 years. The rate of early stage disease in the grade 3 endometrioid group was significantly higher (66.3%-44.9%, p=0.002). In the grade 3 endometrioid group, adnexal invasion rate (13.5%-31.4%, p=0.003), uterine serosal invasion rate (10.1%-22%, p=0.023), positive cytology rate (10.1%-29.7%, p=0.001), lymph node metastasis rate (20.2%-43.2%, p=0.001) and abdominal metastasis rate (9%-28%, p=0.001) were significantly lower than in the serous/clear cell group. There was no significant difference between the two groups in terms of overall survival times of 12-18-24-36 months (p=0.910). According to the univariate analysis between the groups, there was a significant risk for overall survival in age categories (p=0.039) and stages (p=0.034). In the multivariate analysis, age over 63 and advanced stage disease were evaluated as poor prognostic factors. Conclusion: there was no significant difference in survival between grade 3 endometrial cancer and serous and clear cell endometrial cancers. Being over 63 years of age and having advanced-stage disease were considered poor prognostic factors.

  • Yüksek dereceli skuamöz intraepitelyal lezyonlarda eksizyonel işlemler sonrası cerrahi sınır pozitifliğini etkileyen faktörler

    by Şükran Kozali Uzun, Zeliha Firat Cüylan, Koray Aslan, Murat Öz

    Amaç: Servikal preinvaziv lezyonlarda eksizyonel işlemler sonrası cerrahi sınır pozitifliği için risk faktörlerinin değerlendirilmesi Gereçler ve Yöntem: Şubat 2007 ile Eylül 2018 tarihleri arasında Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesinde yüksek dereceli skuamöz intraepitelyal lezyon (HSIL) / servikal intraepitelyal neoplazi (CIN2-3) nedeniyle konizasyon [soğuk konizasyon veya loop elektrocerrahi eksizyon prosedürü (LEEP)] yapılmış hastaların tıbbi kayıtları retrospektif olarak değerlendirildi. Çalışmada hastaların klinik ve demografik özellikleri (yaş, sigara kullanımı, parite, konizasyon öncesi servikal sitoloji, human papilloma virüs (HPV) varlığı, eksizyonel işlemin tipi), konizasyon materyalinin boyutları (horizantal ve vertikal çap) ve cerrahi sınır durumu (pozitif veya negatif) analiz edildi. Bulgular: Konizasyon (LEEP veya soğuk konizasyon) sonrası çalışma kriterlerine uyan toplam 1341 hasta analize dahil edildi. Hastaların %55,1’ine (739/1341) soğuk konizasyon ve %44,9’una (602/1341) LEEP yapılmıştı. Tüm grup incelendiğinde cerrahi sınır pozitiflik oranını toplamda %36,2 olarak bulduk. Soğuk konizasyon yapılan hastalarda cerrahi sınır pozitifliği oranı %30,3 (224/739), LEEP yapılan hastalarda ise bu oran %43,3 (261/602) olarak saptadık (p

  • EPİTELİYAL OVER KANSERİNDE UZUN DÖNEM SAĞ KALIMLA İLİŞKİLİ KLİNİK VE EPIDEMİYOLOJİK ÖZELLİKLER

    by Koray Aslan, Zeliha Firat Cüylan, Şükran Kozali, Murat Öz

    Amaç: Epitelyal over kanseri (EOK) hastalarında uzun dönem sağ kalımla ilişkili klinik ve epidemiyolojik risk faktörlerini tanımlamak. Gereçler ve Yöntem: Jinekolojk onkoloji kliniğimizde Aralık, 2006 ve Ocak, 2019 tarihleri arasında epitelyal over kanseri tansı alan tüm hastaların tıbbi kayıtları incelenmiştir. Çalışmaya EOK tanısı ile evreleme cerrahisi yapılan ve adjuvant platin bazlı kemoterapi alan hastalar dahil edilmiştir. Tıbbi kayıtları eksik, platin dirençli veya Aralık, 2020 tarihi itibatri ile hayatta olup takip süresi 84 aydan kısa olan olgular çalışma dışında bırakılmıştır. Uzun dönem sağ kalım tanı aldıktan sonra ≥7 yıl yaşayan hastaları tanımlamak için kullanılmıştır. Hastalar sağ kalım ≥7 yıl ve sağ kalım

  • Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer?

    by Zeliha Firat Cuylan, Huseyin Akilli, Kemal Gungorduk, Fuat Demirkiran, Murat Oz, Mehmet Coskun Salman, Hamdullah Sozen, Husnu Celik, Mehmet Gokcu, Tugan Bese, et al.

    Aim This study aimed to evaluate the prognostic significance of adequate lymph node dissection (LND) (≥10 pelvic lymph nodes (LNs) and ≥ 5 paraaortic LNs removed) in patients with International Federation of Gynecology and Obstetrics (FIGO) stage II endometrioid endometrial cancer (EEC). Methods A multicenter department database review was performed to identify patients who had been operated and diagnosed with stage II EEC at seven centers in Turkey retrospectively. Demographic, clinicopathological, and survival data were collected and analyzed. Results We identified 284 women with stage II EEC. There were 170 (59.9%) patients in the adequate lymph node dissection (LND) group and 114 (40.1%) in the inadequate LND group. The 5‐year overall survival (OS) rate of the inadequate LND group was significantly lower than that of the adequate LND group (84.1% vs. 89.1%, respectively; p = 0.028). In multivariate analysis, presence of lymphovascular space invasion (LVSI) (hazard ratio [HR]: 2.39, 95% confidence interval [CI]: 1.23–4.63; p = 0.009), age ≥ 60 (HR: 3.30, 95% CI: 1.65–6.57; p = 0.001], and absence of adjuvant therapy (HR: 2.74, 95% CI: 1.40–5.35; p = 0.003) remained as independent risk factors for decreased 5‐year disease‐free survival (DFS). Inadequate LND (HR: 2.34, 95% CI: 1.18–4.63; p < 0.001), age ≥ 60 (HR: 2.67, 95% CI: 1.25–5.72; p = 0.011), and absence of adjuvant therapy (HR: 4.95, 95% CI: 2.28–10.73; p < 0.001) were independent prognostic factors for decreased 5‐year OS in multivariate analysis. Conclusion Adequate LND and adjuvant therapy were significant for the improvement of outcomes in FIGO stage II EEC patients. Furthermore, LVSI was associated with worse 5‐year DFS rate in stage II EEC.


  • Open Access

    Comparison of Survival Outcomes of Lymphovascular Space Invasion-Negative and Lymphovascular Space Invasion - Positive Women with Stage IIIC Endometrioid Endometrial Cancer: A Case - Control Study

    by Zeliha Firat Cuylan, Mehmet Mutlu Meydanli, Murat Öz, Ahmet Taner Turan, Ozgur Akbayir, Murat Dede, Ali Ayhan

    Objective: The purpose of this case-control study was to investigate the effect of lymphovascular space invasion on recurrence patterns and survival in patients with stage IIIC endometrioid type endometrial cancer.Study Design: A multicenter, retrospective, department database review was performed to identify lymphovascular space invasion-negative and lymphovascular space invasion-positive stage IIIC endometrioid endometrial cancer at five gynecological oncology centers in Turkey. Demographic, clinicopathological and survival data were collected. Cases and controls were matched in terms of age at diagnosis, grade of tumor, depth of myometrial invasion, sub-stage and adjuvant treatment.Results: Forty-one patients in the case group and 82 patients in the control group were eligible for the study. The 5-year OS rates were 94.4% in the lymphovascular space invasion-negative group and 77.2% in the LVSI-positive group (p=0.058). Advanced age (58 years) (HR 3.73; 95% CI: 1.19-11.69, p=0.02), grade 3 tumor (HR 2.57; 95% CI: 1.002-6.62, p=0.048) and cervical involvement (HR 2.62; 95% CI: 1.03-6.67, p= 0.04) appeared to be as independent predictors of decreased overall survival (OS). There was a trend towards statistical significance between the presence of lymphovascular space invasion and OS in regression analysis (HR 3.10; 95% CI 0.90-10.67, p=0.05). Recurrence rates were 17.0% (7/41) and 24.4% (20/82) in lymphovascular space invasion-negative and lymphovascular space invasion-positive groups, respectively (p=0.48). There were 5 cases of retroperitoneal recurrences in the lymphovascular space invasion-positive group and no retroperitoneal recurrence among lymphovascular space invasion-negative women.Conclusion: Lymphovascular space invasion status seems to be of borderline significance for OS in stage IIIC endometrioid endometrial cancer and impacts recurrence patterns as retroperitoneal recurrences are strongly related to positive lymphovascular space invasion status.

  • Covid-19 pandemisi sırasında bir pandemi hastanesinde jinekolojik kanser nedeniyle opere olan hastalarda kısa dönem cerrahi sonuçlar: Tek Merkezli Retrospektif Olgu-kontrol çalışması

    by Murat Öz, Müfide İclal Altintaş, Burak Ersak, Zeliha Firat Cüylan, Bülent Özdal, Özlem Moraloğlu Teki̇n

    Amaç Tüm Dünya’da etkisini sürdüren yeni tip koronavirüs (COVID-19) pandemisi sürecinde sağlık sistemi kaynakları pandemi ile mücadeleye aktarılırken rutin sağlık hizmeti sunumunda önemli değişikliklere gidilmiştir. Bu tek merkezli, retrospektif, olgu-kontrol çalışmasının amacı COVID-19 pandemisi sürecinde alınan tedbirlerin jinekolojik kanser cerrahisi uygulanan hastalarda kısa süreli cerrahi sonuçlara etkisini ortaya koymaktır. Gereçler ve Yöntem COVID-19 pandemi önlemlerinin alınmasından sonra opere edilen hastalar çalışma grubunu oluştururken, bu tarihten önce opere edilen hastalar kontrol grubunu oluşturdu. Çalışma grubundaki her bir hastaya karşılık yaş (±10), tanı, evre ve yapılan operasyonun tipi yönünden eşleştirilen en az iki kontrol seçilerek klinikopatolojik değişkenler yönünden karşılaştırıldı. Bulgular Vaka ve kontrol grubu tanı, hastalık evresi ve yapılan ameliyatın şekli yönünden birebir eşleşirken her iki grup yaş, menopozal durum, ko-morbiditeleri ve aldıkları adjuvan tedavi yönünden benzer olarak bulundu. Vaka grubundaki hastaların ortalama hastanede yatış süresinin, kontrol grubundaki hastalara göre anlamlı olarak daha az olduğu görüldü (vaka grubunda ortalama 5,6 (±3,3) gün, kontrol grubunda ortalama 8,5 (±9,3) gün, p=0,021). Vaka grubunda 5 hastaya (%17,2) kontrol grubundaysa 18 hastaya (%31,0) kan ürünü transfüzyonu ihtiyacı oldu, ancak iki grup arasındaki fark istatistiksel olarak anlamlı değildi (p=0,16). Vaka grubundaki hastalarda kontrol grubuna göre daha az intraoperatif (p=0,36) ve postoperatif (p=0,34) komplikasyon izlenmesine karşın bu farklar istatistiksel olarak anlamlılık arz etmiyordu. Sonuç COVID-19 pandemisi sonrasında opere edilen hastalarda daha az radikal cerrahi tercih edilmesi ile birlikte tutarlı bir şekilde hastanede yatış süresi, intraoperatif ve postoperatif komplikasyon oranlarının azaldığı ancak hastanede kalış süresi haricindeki değişkenlerin istatistiksel olarak anlamlı olmadığı bulunmuştur.


  • Comparison of clinicopathologic characteristics and survivals in patients with uterine serous and clear cell carcinoma

    by Zeliha Firat Cüylan, Koray Aslan, Vakkas Korkmaz, Murat Öz, Mehmet Mutlu Meydanli̇

    Aim: We aimed to compare the clinicopathological characteristics and survivals between uterine serous carcinoma (USC) and uterine clear cell carcinoma (UCCC).Materials and Methods: The study population consists of women who were diagnosed with USC and UCCC according to the final pathology reports. Demographic, clinicopathological and survival data were collected and analyzed.Results: A total of 69 patients with USC and 36 patients with UCCC were included in the final analysis. Patients in the USC group tend to have more advanced stage disease compared to the patients in the UCCC group and this was statistically significant between the groups (61.1% vs 36.2%, respectively; p=0.015). Patients with USC were more likely to have omental metastasis (17/69 vs 2/36, p=0.016) and positive peritoneal cytology (25/69 vs 5/36, p=0.016). In the multivariate analysis, only positive peritoneal cytology remained as an independent prognostic factor for decreased disease free survival (DFS) for the entire cohort (HR 5.07, 95% CI 2.07-12.42; p<0.001). Only positive peritoneal cytology was an independent prognostic factor for decreased overall survival (OS) for the entire cohort (HR 3.50, 95% CI 1.31-9.33; p=0.012) in the multivariate analysis.Conclusion: We concluded that positive peritoneal cytology was an independent prognostic factor for both DFS and OS in patients with USC and UCCC in the current study. Because of the high rate of omental metastasis in the USC group, we also suggest performing an omentectomy as a part of the comprehensive surgical staging surgery.

  • Open Access

    Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus

    by Hanifi Sahin, Mehmet Mutlu Meydanli, Mustafa Erkan Sari, Eda Kocaman, Zeliha Firat Cuylan, Ibrahim Yalcin, Gonca Coban, Özlem Özen, Levent Sirvan, Tayfun Güngör, et al.


  • Open Access

    Is There any Impact of Local Endometrial Injury on Implantation and Clinical Pregnancy Rates in the First in Vitro Fertilization Cycles

    by Zeliha Firat Cuylan, Berfu Demi̇r, Berna Di̇lbaz, Serdar Di̇lbaz

    Objective: To evaluate the impact of local endometrial injury (LEI), applied during the first in vitro fertilization (IVF)-embryo transfer (ET) cycle using office hysteroscopy, on implantation and pregnancy rates. Material and Methods: A total of 372 women under the age of 40, who had their first IVF-ET treatment cycle, with no ovulatory or intracavitary pathology were included in this study. LEI was created in the fundus, anterior and posterior endometrial walls during Office hysteroscopy, which was performed prior to the IVF-ET cycle. Long luteal gonadotropin releasing hormone agonist protocol was used in all cycles and 273 patients underwent embryo transfer. Implantation and pregnancy rates were compared to the control group. Results: Age, body mass index, baseline follicle stimulating hormone, luteinizing hormone, and estradiol levels, antral follicle counts, infertility etiologies, total oocyte counts, intra-cytoplasmic sperm injection percentages were similar, both in the study and the control groups. Clinical pregnancy rates (28.7% vs 26.1%, p>0.05), total pregnancy rates (43.1% vs 38%, p>0.05) and implantation rates (19% vs 12.9%, p>0.05) of the LEI injury group were higher than those of the control group, however the difference was not statistically significant. There was no statistically significant difference between the miscarriage rates. Conclusion: Even if implantation and pregnancy rates improved slightly in LEI group, the study did not reveal a significant improvement for the implantation and pregnancy rates after the LEI, which was created during hysteroscopy before the first IVF-RT treatment cycle.